sr141716 has been researched along with Lymphoma, Mantle-Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Christensson, B; Flygare, J; Gustafsson, K; Kimby, E; Sander, B | 1 |
1 other study(ies) available for sr141716 and Lymphoma, Mantle-Cell
Article | Year |
---|---|
Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma.
Topics: Animals; Arachidonic Acids; Benzoxazines; Biopsy; Breast Neoplasms; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cannabinoids; Cell Death; Cell Division; Cell Line; Cell Line, Transformed; Cell Line, Tumor; Cell Transformation, Viral; Cells, Cultured; Dose-Response Relationship, Drug; Endocannabinoids; Female; Flow Cytometry; Humans; Leukemia, Plasma Cell; Ligands; Lymphoma, Mantle-Cell; Mice; Morpholines; Naphthalenes; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptors, Cannabinoid; Rimonabant | 2005 |